| Trial Identifier: | D6090C00002 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT03236974 |
| Start Date: | October 2017 |
| Primary Completion Date: | February 2019 |
| Study Completion Date: | February 2019 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation | |
| German Translation |
| Country | Location |
|---|---|
| Germany | Berlin, Germany, 10117 |
| Germany | Erlangen, Germany, 91054 |
| Germany | Kiel, Germany, 24105 |
| Germany | Köln, Germany, 50935 |
| Germany | Minden, Germany, 32429 |
| Germany | Mönchengladbach, Germany, 41061 |
| Germany | München, Germany, 81377 |
| Germany | Schwerin, Germany, 19049 |
| United Kingdom | Birmingham, United Kingdom, B15 2TG |
| United Kingdom | Bournemouth, United Kingdom, BH7 7DW |
| United Kingdom | Derby, United Kingdom, DE22 3DT |
| United Kingdom | Edinburgh, United Kingdom, EH4 2XU |
| United Kingdom | London, United Kingdom, W12 0NN |
| United Kingdom | London, United Kingdom, EC1M 6BQ |
| United Kingdom | London, United Kingdom, SE1 9RT |
| United Kingdom | Manchester, United Kingdom, M23 9LT |
| United Kingdom | Poole, United Kingdom, BH15 2JB |
| United Kingdom | Sutton In Ashfield, United Kingdom, NG17 4JL |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company